Darwin Wealth Management LLC Acquires Shares of 502 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Darwin Wealth Management LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 502 shares of the medical equipment provider’s stock, valued at approximately $223,000.

A number of other institutional investors have also added to or reduced their stakes in ISRG. Creekmur Asset Management LLC grew its holdings in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares in the last quarter. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $26,000. Able Wealth Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $28,000. Delos Wealth Advisors LLC grew its holdings in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new position in shares of Intuitive Surgical in the first quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at $757,625. The disclosure for this sale can be found here. Insiders sold a total of 50,555 shares of company stock valued at $24,267,737 over the last three months. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $494.01 on Friday. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $494.15. The company has a 50-day moving average of $462.82 and a 200 day moving average of $420.84. The firm has a market cap of $175.55 billion, a PE ratio of 89.17, a price-to-earnings-growth ratio of 5.41 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. During the same period in the prior year, the firm earned $1.18 earnings per share. The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. BTIG Research raised their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. The Goldman Sachs Group initiated coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, Barclays raised their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.